Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02386800
Title CINC424A2X01B Rollover Protocol
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

myelofibrosis

Therapies

Ruxolitinib

Panobinostat + Ruxolitinib

Age Groups: child | adult | senior
Covered Countries ITA | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Completed Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site Completed St Leonards New South Wales 2065 Australia Details
Novartis Investigative Site Completed Herston Queensland 4029 Australia Details
Novartis Investigative Site Completed Wooloongabba Queensland 4102 Australia Details
Novartis Investigative Site Completed Bedford Park South Australia 5041 Australia Details
Novartis Investigative Site Completed Box Hill Victoria 3128 Australia Details
Novartis Investigative Site Completed Clayton Victoria 3168 Australia Details
Novartis Investigative Site Completed Franston Victoria 3199 Australia Details
Novartis Investigative Site Completed Perth Western Australia 6000 Australia Details
Novartis Investigative Site Completed Antwerpen 2060 Belgium Details
Novartis Investigative Site Completed Brugge 8000 Belgium Details
Novartis Investigative Site Recruiting Leuven 3000 Belgium Details
Novartis Investigative Site Recruiting Liege 4000 Belgium Details
Novartis Investigative Site Active, not recruiting Pleven 5800 Bulgaria Details
Novartis Investigative Site Active, not recruiting Plovdiv 4002 Bulgaria Details
Novartis Investigative Site Completed Sofia 1413 Bulgaria Details
Novartis Investigative Site Active, not recruiting Sofia 1431 Bulgaria Details
Novartis Investigative Site Completed Santiago RM 7500922 Chile Details
Novartis Investigative Site Completed Vina del Mar Valparaiso 2540364 Chile Details
Novartis Investigative Site Completed Santiago 8420383 Chile Details
Novartis Investigative Site Recruiting Beijing Beijing 100730 China Details
Novartis Investigative Site Completed Hangzhou Zhejiang 310003 China Details
Novartis Investigative Site Withdrawn Copenhagen DK-2100 Denmark Details
Novartis Investigative Site Active, not recruiting Paris Cedex 10 75475 France Details
Novartis Investigative Site Active, not recruiting Aachen 52074 Germany Details
Novartis Investigative Site Completed Dresden 01307 Germany Details
Novartis Investigative Site Completed Hamburg 20246 Germany Details
Novartis Investigative Site Active, not recruiting Magdeburg 39120 Germany Details
Novartis Investigative Site Active, not recruiting Mainz 55131 Germany Details
Novartis Investigative Site Completed Ulm 89081 Germany Details
Novartis Investigative Site Completed Athens GR 115 27 Greece Details
Novartis Investigative Site Completed Patras 265 00 Greece Details
Novartis Investigative Site Completed Budapest 1097 Hungary Details
Novartis Investigative Site Completed Debrecen 4032 Hungary Details
Novartis Investigative Site Completed Kaposvar 7400 Hungary Details
Novartis Investigative Site Completed Kecskemet 6001 Hungary Details
Novartis Investigative Site Completed Szeged H 6725 Hungary Details
Novartis Investigative Site Completed Szombathely 9700 Hungary Details
Novartis Investigative Site Recruiting Pune Maharashtra 411004 India Details
Novartis Investigative Site Completed Afula 1834111 Israel Details
Novartis Investigative Site Completed Jerusalem 9112001 Israel Details
Novartis Investigative Site Active, not recruiting Ancona AN 60126 Italy Details
Novartis Investigative Site Completed Bari BA 70124 Italy Details
Novartis Investigative Site Completed Bologna BO 40138 Italy Details
Novartis Investigative Site Recruiting Brescia BS 25123 Italy Details
Novartis Investigative Site Active, not recruiting San Giovanni Rotondo FG 71013 Italy Details
Novartis Investigative Site Recruiting Firenze FI 50134 Italy Details
Novartis Investigative Site Completed Milano MI 20122 Italy Details
Novartis Investigative Site Recruiting Milano MI 20132 Italy Details
Novartis Investigative Site Completed Milano MI 20162 Italy Details
Novartis Investigative Site Active, not recruiting Rozzano MI 20089 Italy Details
Novartis Investigative Site Completed Palermo PA 90146 Italy Details
Novartis Investigative Site Recruiting Palermo PA 90146 Italy Details
Novartis Investigative Site Recruiting Pavia PV 27100 Italy Details
Novartis Investigative Site Recruiting Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Completed Roma RM 00161 Italy Details
Novartis Investigative Site Recruiting Roma RM 00165 Italy Details
Novartis Investigative Site Completed Orbassano TO 10043 Italy Details
Novartis Investigative Site Recruiting Varese VA 21100 Italy Details
Novartis Investigative Site Completed Napoli 80131 Italy Details
Novartis Investigative Site Active, not recruiting Nagoya Aichi 453-8511 Japan Details
Novartis Investigative Site Recruiting Nagoya Aichi 466 8560 Japan Details
Novartis Investigative Site Recruiting Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Recruiting Sapporo city Hokkaido 060 8648 Japan Details
Novartis Investigative Site Recruiting Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Recruiting Suita Osaka 565 0871 Japan Details
Novartis Investigative Site Recruiting Bunkyo ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Active, not recruiting Osaka 545-8586 Japan Details
Novartis Investigative Site Recruiting Seoul Seocho Gu 06591 Korea, Republic of Details
Novartis Investigative Site Recruiting Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Recruiting Seoul 03722 Korea, Republic of Details
Novartis Investigative Site Completed Beirut 1107 2020 Lebanon Details
Novartis Investigative Site Active, not recruiting Monterrey Nuevo Leon 64718 Mexico Details
Novartis Investigative Site Active, not recruiting Gliwice Slaskie 44-101 Poland Details
Novartis Investigative Site Active, not recruiting Wroclaw 50 367 Poland Details
Novartis Investigative Site Completed Lisboa 1099 023 Portugal Details
Novartis Investigative Site Active, not recruiting Lisboa 1649-035 Portugal Details
Novartis Investigative Site Completed Moscow 125167 Russian Federation Details
Novartis Investigative Site Recruiting Moscow 125167 Russian Federation Details
Novartis Investigative Site Completed Moscow 129110 Russian Federation Details
Novartis Investigative Site Completed Petrozavodsk 185019 Russian Federation Details
Novartis Investigative Site Recruiting Sain Petersburg 197022 Russian Federation Details
Novartis Investigative Site Withdrawn Bratislava 833 40 Slovakia Details
Novartis Investigative Site Completed Soweto Gauteng 2013 South Africa Details
Novartis Investigative Site Recruiting Cape Town Western Province 7800 South Africa Details
Novartis Investigative Site Completed Pretoria 0027 South Africa Details
Novartis Investigative Site Recruiting Pretoria 0044 South Africa Details
Novartis Investigative Site Completed Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Completed Barcelona Catalunya 08003 Spain Details
Novartis Investigative Site Completed Pamplona Navarra 31008 Spain Details
Novartis Investigative Site Active, not recruiting Huddinge SE-14186 Sweden Details
Novartis Investigative Site Active, not recruiting Lulea SE 971 80 Sweden Details
Novartis Investigative Site Active, not recruiting Lund SE-221 85 Sweden Details
Novartis Investigative Site Active, not recruiting Uddevalla 451 80 Sweden Details
Novartis Investigative Site Completed Bangkok Bangkoknoi 10700 Thailand Details
Novartis Investigative Site Completed Bangkok 10700 Thailand Details
Novartis Investigative Site Recruiting Ankara Sihhiye 06100 Turkey Details
Novartis Investigative Site Recruiting Istanbul 34093 Turkey Details
Novartis Investigative Site Recruiting Izmir 35040 Turkey Details
Novartis Investigative Site Recruiting Talas / Kayseri 38039 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field